Contact Us

In the News

Aardvark Therapeutics has been featured in numerous online resources and media sites.

Updates
Publications
Presentations

Emerging from stealth mode, Aardvark rounds up enough cash to put its lead drug through Prader-Willi PhII

Josh Sullivan, Associate Editor Endpoints News – August 5 2021 When Aardvark Therapeutics CEO Tien Lee started his work on...

READ MORE »

Aardvark Therapeutics, Inc., Announces the Initiation of Enrollment For Three Phase 2 Clinical Trials of Oral ARD-101

- Two studies evaluate ARD-101 in Obesity: one in General Obesity and the other in Refractory Weight Gain Post-Bariatric Surgery...
READ MORE »

Aardvark Therapeutics, Inc., Announces it has been Invited to Present at the 40th Annual J.P. Morgan Health Care Conference

– Will update investors on progress during 2021 – Announce plans for 2022 Jan. 10, 2022 – Aardvark proudly announces...

READ MORE »

Aardvark Therapeutics, Inc., Announces Poster Presentations at the 2020 Obesity Week Conference

San Diego, Calif., November 2, 2020 – Aardvark Therapeutics, Inc., today announced that it will present two posters at the 2020...

READ MORE »
Load More

Get in Touch to Discover More

Contact Us
Instagram Facebook Linkedin
© 2025 Aardvark Therapeutics, Inc. All Rights Reserved.
Contact Us
Instagram Facebook Linkedin